CLYM – climb bio, inc. (US:NASDAQ)
Stock Stats
News
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a Must-Buy Small Cap Stock? [Yahoo! Finance]
Climb Bio: 'Buy' On Budoprutug Phase 2 Advancement pMN And Expansions Underway [Seeking Alpha]
Climb Bio (CLYM) was upgraded by Mizuho to "strong-buy".
Climb Bio (CLYM) was given a new $18.00 price target by Mizuho.
Climb Bio (CLYM) had its "buy" rating reaffirmed by BTIG Research. They now have a $8.00 price target on the stock.
Form PRE 14A Climb Bio, Inc. For: Jun 05
Form 8-K Climb Bio, Inc. For: Apr 01
Form S-8 Climb Bio, Inc.
Form 10-K Climb Bio, Inc. For: Dec 31
Form 8-K Climb Bio, Inc. For: Mar 05
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.